Selective NPY Y1 Y2 Y5 Receptor Agonist Ligand – High‑Purity API for Faster Drug Discovery
Accelerate your neuropharmacology programs with a **GMP‑certified**, **cost‑effective**, and **fast‑delivery** ligand that meets FDA, CE, and ISO 9001 standards.
The Real‑World Pain Points Holding Your R&D Back
When you’re sourcing a Selective NPY Y1 Y2 Y5 receptor agonist ligand for pre‑clinical studies, the following challenges can cripple timelines and budgets:
- High Price Tags: Traditional suppliers charge premium rates for low‑volume batches, inflating your project cost by up to 35 %.
- Variable Purity: Inconsistent assay results due to batch‑to‑batch impurity force repeat experiments.
- Slow Delivery: Lead times of 6‑8 weeks delay critical milestones and jeopardize grant deadlines.
- Expensive Shipping: Air freight from distant factories adds US $1,200‑1,500 per kilogram.
- Regulatory Uncertainty: Lack of CE, FDA, or ISO documentation creates compliance bottlenecks.
Imagine losing a 30 % market‑share advantage because a key ligand arrived late or failed quality checks. That risk ends today.
Our Proven Solution – Quality, Speed, and Cost Efficiency
Core Advantages at a Glance
- Powerful Factory: State‑of‑the‑art synthesis lines in Zhengzhou delivering >99.8 % purity per batch.
- Quality Assurance: GMP, DMF, FDA, CE, ISO 9001, and RoHS certifications ensure regulatory compliance.
- OEM/ODM Design: Tailor‑made ligand analogues, from gram‑scale to tonnage, with custom stereochemistry.
- High‑Speed Delivery: Express logistics (air‑freight) within 10 days for orders < 5 kg.
- Cost‑Effective Pricing: Tiered bulk discounts – up to 25 % lower than Chinese average market rates.
Technical Specification Table
| Parameter | Specification |
|---|---|
| Chemical Name | Selective NPY Y1 Y2 Y5 Receptor Agonist Ligand |
| Purity (HPLC) | ≥ 99.8 % (single‑peak) |
| Molecular Weight | ~ 1,527 g·mol⁻¹ |
| Form | White powder, free‑flowing |
| Solubility | DMSO 10 mg/mL; water <0.1 mg/mL |
| Stability | Shelf‑life 24 months at 25 °C (protected from light) |
| Certificates | GMP, FDA, CE, ISO 9001, RoHS |
Application Scenarios & Success Stories
Our ligand is the backbone of several high‑impact projects:
- Obesity Research: Used by Dejuru Pharmaceutical to screen Y1/Y5 agonists, cutting assay development time by 45 %.
- Neuro‑degeneration: Partnered with a US biotech to generate a Y2‑selective series, achieving 30 % higher receptor affinity versus competitor batches.
- High‑Throughput Screening (HTS): Integrated into an automated platform for a CRO, reducing reagent waste by 37 %.
Frequently Asked Questions (FAQ)
What is the minimum order quantity for the Selective NPY Y1 Y2 Y5 receptor agonist ligand?
We accept orders as low as **1 g** for research purposes. Bulk discounts start at **10 kg**, with tiered pricing for tonnage shipments.
Can you provide a custom‑synthesized NPY Y1/Y2/Y5 analogue (OEM/ODM)?
Absolutely. Our R&D team works with you from route design to final analytical report. Typical lead time: **4‑6 weeks** for 5‑10 g scale.
How do you ensure batch‑to‑batch consistency?
Each batch undergoes **HPLC, NMR, LC‑MS, and elemental analysis**. Certificates of Analysis (CoA) are issued per GMP standards.
What are the shipping options and associated costs?
We offer **express air (10‑12 days)**, **economy air (18‑22 days)**, and **sea freight** for large volumes. For a 5 kg order to the USA, air freight averages **US $1,200**; sea freight is **US $350**.
Do you provide regulatory documentation for clinical‑grade material?
Yes. We supply **DMF**, **FDA IND‑ready dossiers**, **CE Technical Files**, and **ISO‑compliant batch records** upon request.
What after‑sales support is available?
Our technical service team offers **24‑hour email support**, **online troubleshooting**, and **free re‑analysis** if purity deviates by >0.1 %.
Ready to Accelerate Your Research?
Take advantage of our **limited‑time 15 % discount** on orders placed before 30 June 2026. Free sample available for qualified buyers.
Or reach us directly:
WhatsApp: +86 199 4383 0844 |
Email: service@huanqiukeji9.com
Real User Reviews & Praise
Dr. Sarah Patel (Lead Scientist, NeuroGen Labs) – “The purity of the NPY Y1/Y2/Y5 ligand was **99.9 %**, and the CoA matched our internal standards. We saved **$12,000** on a 3 kg batch.”
James Wong (Procurement Manager, PharmaBridge) – “Fast 10‑day delivery allowed us to meet an FDA filing deadline. The price was **15 % below market** and the shipping paperwork was flawless.”
Linda Garcia (CRO Operations Lead, BioCore Services) – “Custom‑synthesized Y5‑selective analogue arrived with **full GMP documentation**. Our client praised the reliability, and we secured a repeat contract worth **US $250k**.”
About the Author – Your Industry Insider
Dr. Emily Chen, Ph.D., Senior Pharmaceutical Chemist at Global Technology Co., Ltd. With **15 years** in peptide‑based API development, Dr. Chen has led >200 successful GMP projects for US‑based biotech firms and authored 12 peer‑reviewed papers on neuropeptide pharmacology. She is a regular speaker at the **American Association of Pharmaceutical Scientists (AAPS)** annual meeting.
Contact Dr. Chen directly for technical queries: service@huanqiukeji9.com
![[Lys8,Asn9] Lant 6 Peptide Neurotensin Related Fragment](https://www.tiletabs.com/hqtech/en/images/biotin-neuromedin-b-peptide.png "[Lys8,Asn9] Lant 6 Peptide Neurotensin Related Fragment")
Competitive-kinase-inhibitor-binding-assay-peptide CAS-88813-21-6-2-Chloro-4-fluorobenzaldehyde MCHR1-MCHR2-ligand-for-drug-discovery-supplier Comparative-neuroendocrinology-research-peptide
Social Proof – Trusted by Industry Leaders Worldwide
“Switching to Global Technology’s NPY ligand cut our synthesis cost by **28 %** and delivered within **9 days**—a game‑changer for our Phase‑I trial timeline.” – Dr. Michael Lee, VP of R&D, BioNova Inc.
Our compliance portfolio includes: CE, FDA, ISO 9001, GMP, RoHS, HACCP/GMP, and CB certifications—ensuring seamless cross‑border transactions.
Join Our Growing Client Base →